Uptravi Tablets 0.4mg (ウプトラビ錠0.4mg)

Land: Japan

Sprog: engelsk

Kilde: すりの適正使用協議会 RAD-AR Council, Japan

Køb det nu

Hent Indlægsseddel (PIL)
01-08-2021

Aktiv bestanddel:

Selexipag

Tilgængelig fra:

Nippon Shinyaku Co., Ltd.

INN (International Name):

Selexipag

Lægemiddelform:

pale reddish brown tablet, diameter: 7.1 mm, thickness: 3.4 mm

Produkt oversigt:

Print on wrapping: (face) ウプトラビ錠0.4mg 262 0.4
(back) Uptravi Tab.0.4mg ウプトラビ錠 0.4mg 0.4

Indlægsseddel

                                Drug Information Sheet("Kusuri-no-Shiori")
Internal
Revised: 08/2021
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
UPTRAVI TABLETS 0.4MG
ACTIVE INGREDIENT:
Selexipag
DOSAGE FORM:
pale reddish brown tablet, diameter: 7.1 mm, thickness: 3.4
mm
IMPRINT OR PRINT ON WRAPPING:
(face) ウプトラビ錠 0.4mg 262 0.4
(back) Uptravi Tab.0.4mg ウプトラビ錠 0.4mg 0.4
EFFECTS OF THIS MEDICINE
This medicine reduces blood pressure in the pulmonary artery and
increases quantity of blood
pumped into the pulmonary artery. It consequently improves shortness
of breath and fatigue.
It is usually used to treat pulmonary artery hypertension and chronic
thromboembolic
pulmonary hypertension.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have liver disorder or pulmonary hypertension accompanied by
pulmonary venous
occlusive disease.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         
           
to be written by a healthcare
professional
))
・In general, for adults, start taking 0.2 mg of the active
ingredient at a time, twice a day after
meals. Then the dose will be increased by 0.2 mg per dose in at least
7-day intervals, while
checking the tolerabili
                                
                                Læs hele dokumentet
                                
                            

Søg underretninger relateret til dette produkt